Contents
Contents
In the Trans Star Ambulance settlement, Lafferty Enterprises, LLC agreed to pay $948,000 to resolve allegations that it billed Medicare for unnecessary dialysis ambulance rides. The company operated as Trans-Star Ambulance Services in Floyd County, Kentucky. A former owner of another eastern Kentucky ambulance company brought the whistleblower complaint that prompted the investigation.
The Justice Department’s January 26, 2015 announcement described routine, non-emergency trips for patients who could safely travel by other means. It also explained something the settlement figure alone cannot tell you: Trans-Star’s financial ability to pay helped determine the amount. The Department of Health and Human Services Office of Inspector General, the Kentucky Attorney General’s Medicaid Fraud and Abuse Control Unit and the U.S. Attorney’s Office conducted the investigation.
The government alleged that Trans-Star billed Medicare for medically unnecessary ambulance transportation to and from dialysis clinics from February 1, 2006 through December 31, 2012. The accusation concerned patients who could safely make those trips by other means. The company resolved those allegations under the False Claims Act.
That is the recurring problem in dialysis ambulance fraud: the treatment schedule supplies a continuing series of journeys, while ambulance coverage depends on the patient’s medical need for that kind of transportation. The dialysis appointment explains the destination. It does not explain why the patient needs an ambulance to reach it.
The difference matters to a crew member who sees the patient at pickup, a clinic employee who sees the arrival and a biller who sees the description submitted for payment. A recurring appointment can stay on the calendar while the patient’s condition changes. We look at what the patient needed on the billed trip and how that need was described through the operation.
Yes. Medicare covers medically necessary non-emergency ambulance transportation when the patient meets its coverage conditions, including a medical condition that makes other transportation unsafe. The Medicare ambulance coverage rule requires the patient’s condition to support both the ambulance ride and the level of service billed.
The Centers for Medicare & Medicaid Services’ ambulance benefit manual makes the practical distinction clear. If another form of transportation could be used without endangering the patient, the manual says Medicare cannot pay for the ambulance, whether or not that alternative is actually available. A transportation problem and a medical need for an ambulance are different questions.
The Trans-Star investigation began with a complaint from a former competing ambulance-company owner. Across ambulance cases, a competing operator may see prices offered to facilities and shifts in referrals that a crew member inside the winning company never sees. That is a different view of the same business. The crew knows the trip. The biller knows the claim. The competing operator knows the market in which the work was won.
The government said it based the settlement on the penalties associated with the alleged violations and Trans-Star’s financial ability to pay. We see the absurdity: the company accused of billing for unnecessary rides had its own finances help set the price of settling. The settlement figure tells us about the company’s wallet, not what those rides cost Medicare.
The Justice Department also announced that the former competing owner would receive a whistleblower reward. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
A corporate integrity agreement sets compliance obligations through an agreement with the Department of Health and Human Services Office of Inspector General. In Trans-Star’s case, the Justice Department announced substantial internal compliance reforms and third-party review of claims to federal health care programs for three years.
That part of the resolution looked forward. The settlement addressed past billing allegations, while the review commitment called for outside examination of later claims. For an ambulance operation, the records supporting those claims include the account of the patient’s condition, the service provided and the reason other transportation was unsafe.
For an unnecessary dialysis transport case, the useful evidence connects the patient’s condition to the certification, the crew’s account and the claim submitted for payment. We work with the part of that chain you know, whether it comes from the ambulance operation, the treating facility or a competing transport business.
The Department of Health and Human Services Office of Inspector General’s 2003 guidance for ambulance suppliers called for run reports to explain the patient’s condition and why other transportation was unsafe. Those details let us connect a clinical description to a particular journey and bill.
Physician certification statements and the patient’s medical records support the claim together. A signature alone does not establish that the ambulance was medically necessary.
The run report describes the patient’s condition and the service provided on the trip. Comparing that account with the certification and billed service can expose where the descriptions diverge. When the issue is a run report changed for billing, the original account and the instruction to change it can explain how the claim acquired a different medical story.
The handoff from facility to ambulance company has mattered in other cases. In a separate Maine resolution announced in 2018, Maine Medical Center settled allegations that its personnel supplied North East Mobile Health Services with inaccurate or incomplete medical-necessity statements. The person providing the clinical description can sit outside the company submitting the bill.
Other dialysis cases show why an insider’s knowledge of transportation choices matters. In the Nelson Ambulance Service and Access Ambulance Service settlement, announced in May 2015, the government alleged unnecessary scheduled ambulance rides to dialysis. It compared an average ambulance round trip of about $380 with wheelchair-van trips of about $60 for some of the same patients traveling to other appointments.
That comparison puts the patient back into the billing story. The question is what made an ambulance medically necessary for the trip Medicare paid for. Someone familiar with the patient’s other journeys may know something the claim does not reveal. The medical condition at the time of each transport is what gives that comparison its meaning.
For an ambulance insider, the most useful account connects the business you recognize with the patients, records and billing decisions you know firsthand. That is where our work with you begins.
If the dialysis rides you saw do not match the medical story sent into billing, speak to one of our Whistleblower Experts about that mismatch. We help build your strongest ambulance fraud whistleblower case, bring in healthcare fraud whistleblower lawyers who understand medical-necessity disputes and stay beside you through the case.